Literature DB >> 19585551

Factors influencing antibody stability at solid-liquid interfaces in a high shear environment.

James G Biddlecombe1, Graeme Smith, Shahid Uddin, Sandrine Mulot, David Spencer, Chris Gee, Brendan C Fish, Daniel G Bracewell.   

Abstract

A rotating disk shear device was used to study the effect of interfacial shear on the structural integrity of human monoclonal antibodies of IgG4 isotype. Factors associated with the solution conditions (pH, ionic strength, surfactant concentration, temperature) and the interface (surface roughness) were studied for their effect on the rate of IgG4 monomer loss under high shear conditions. The structural integrity of the IgG4 was probed after exposure to interfacial shear effects by SDS-PAGE, IEF, dynamic light scattering, and peptide mapping by LC-MS. This analysis revealed that the main denaturation pathway of IgG4 exposed to these effects was the formation of large insoluble aggregates. Soluble aggregation, breakdown in primary structure, and chemical modifications were not detected. The dominant factors found to affect the rate of IgG4 monomer loss under interfacial shear conditions were found to be pH and the nanometer-scale surface roughness associated with the solid-liquid interface. Interestingly, temperature was not found to be a significant factor in the range tested (15-45 degrees C). The addition of surfactant was found to have a significant stabilizing effect at concentrations up to 0.02% (w/v). Implications of these findings for the bioprocessing of this class of therapeutic protein are briefly discussed. 2009 American Institute of Chemical Engineers Biotechnol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585551     DOI: 10.1002/btpr.211

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

1.  Application of fluorescence spectroscopy to quantify shear-induced protein conformation change.

Authors:  Efrosyni Themistou; Indrajeet Singh; Chengwei Shang; Sathy V Balu-Iyer; Paschalis Alexandridis; Sriram Neelamegham
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

2.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

3.  Antibody adsorption on the surface of water studied by neutron reflection.

Authors:  Charles Smith; Zongyi Li; Robert Holman; Fang Pan; Richard A Campbell; Mario Campana; Peixun Li; John R P Webster; Steven Bishop; Rojaramani Narwal; Shahid Uddin; Christopher F van der Walle; Jian R Lu
Journal:  MAbs       Date:  2017-02-10       Impact factor: 5.857

4.  Machine Learning Analysis Provides Insight into Mechanisms of Protein Particle Formation Inside Containers During Mechanical Agitation.

Authors:  Nidhi G Thite; Saba Ghazvini; Nicole Wallace; Naomi Feldman; Christopher P Calderon; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2022-07-11       Impact factor: 3.784

Review 5.  Protein aggregation and its impact on product quality.

Authors:  Christopher J Roberts
Journal:  Curr Opin Biotechnol       Date:  2014-08-28       Impact factor: 9.740

6.  Effect of microencapsulation shear stress on the structural integrity and biological activity of a model monoclonal antibody, trastuzumab.

Authors:  Ritesh M Pabari; Benedict Ryan; Catherine McCarthy; Zebunnissa Ramtoola
Journal:  Pharmaceutics       Date:  2011-08-24       Impact factor: 6.321

7.  Control of protein particle formation during ultrafiltration/diafiltration through interfacial protection.

Authors:  Daniel J Callahan; Bradford Stanley; Yuling Li
Journal:  J Pharm Sci       Date:  2014-01-21       Impact factor: 3.534

8.  Understanding the relationship between biotherapeutic protein stability and solid-liquid interfacial shear in constant region mutants of IgG1 and IgG4.

Authors:  Roumteen Tavakoli-Keshe; Jonathan J Phillips; Richard Turner; Daniel G Bracewell
Journal:  J Pharm Sci       Date:  2013-12-19       Impact factor: 3.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.